[1] [2] In terms of timeline, early changes in appetite and food intake may be noticed within the first two to four weeks of starting treatment, even at lower starting doses
More serous B12 deficiencies have the potential to impair heart and neurological function, leading to a wide range of serous symptoms, including but not limited to tinnitus, severe joint pain, memory problems, depression, anxiety, poor muscle function, ataxia, and changes in reflexes
Takeaway: GLP-1 receptor agonists are not just another drug. Theyre redefining the standard of care in diabetes, obesity, and cardiovascular medicine
Although these studies also showed the potential of dual GCGR/GLP-1R agonism, the current study of survodutide produced greater HbA 1c and bodyweight reductions after a shorter treatment duration than the Phase II studies of cotadutide, again highlighting the potential greater therapeutic efficacy of survodutide
6 Insulin also promotes several other cellular processes, in addition to glucose homeostasis, including regulation of glycogen synthesis, lipid metabolism, DNA synthesis, gene transcription, amino acid transport, protein synthesis and degradation 7